Oct 20, 2026 11:26AM
Oct 20, 2026 09:03AM
Oct 20, 2026 08:30AM
Oct 15, 2026 04:05PM
Sep 16, 2026 08:00AM
Sep 16, 2026 08:00AM
Jul 31, 2026 01:08AM Myriad Genetics (MYGN) Misses Q2 EPS by 19c ; Offers Guidance
Jul 30, 2026 04:07PM
Jul 30, 2026 04:05PM
Jul 23, 2026 09:05AM
May 6, 2026 02:50AM
May 5, 2026 04:05PM
Apr 28, 2026 04:05PM
Feb 23, 2026 04:16PM Myriad Genetics (MYGN) Tops Q4 EPS by 6c, Offers Guidance
Feb 23, 2026 04:05PM
Feb 16, 2026 04:15PM
Jan 12, 2026 08:32AM
Jan 12, 2026 08:30AM
Nov 3, 2025 04:44PM
Nov 3, 2025 04:05PM
Nov 3, 2025 04:05PM Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
Oct 27, 2025 04:15PM
Aug 18, 2025 08:30AM
Aug 18, 2025 08:30AM
Aug 5, 2025 04:36PM
Aug 5, 2025 04:05PM
Jul 31, 2025 08:30AM
Jul 31, 2025 08:30AM Myriad Genetics Announces New $200 Million Credit Facility
Jul 29, 2025 04:05PM
Jul 25, 2025 12:02PM
May 7, 2025 12:46AM
May 6, 2025 04:05PM
Apr 29, 2025 09:00AM
Feb 24, 2025 05:02PM
Feb 24, 2025 04:07PM Myriad Genetics (MYGN) Announces Senior Leadership Transition
Feb 24, 2025 04:05PM
Feb 24, 2025 04:05PM
Feb 18, 2025 08:30AM
Jan 15, 2025 09:00AM
Jan 15, 2025 08:32AM
Jan 15, 2025 08:30AM
Dec 10, 2024 06:26PM Myriad Genetics Provides Update on Discussions with UnitedHealthcare regarding Medical Policy for Pharmacogenetic Testing
Nov 7, 2024 04:46PM
Nov 7, 2024 04:05PM
Nov 4, 2024 08:40AM
Nov 4, 2024 08:39AM
Oct 30, 2024 08:00AM
Oct 1, 2024 06:47AM
Aug 6, 2024 04:05PM Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
Jul 30, 2024 08:00AM

1,233,814 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All